A US-China Economic and Security Review Commission report highlights China’s tightening grip on APIs, biomanufacturing, and R ...
Every day, millions of Americans depend on prescription drugs for conditions ranging from infections to cancer. Yet, the ...
Bayer opened a new biotech incubator in Beijing. A first-of-its-kind biosimilar originally developed by Shanghai Henlius ...
Alex Mitchell, Vice President, Operations, Sentry BioPharma Services, discusses the growing use of FTZs by pharmaceutical ...
The assured, consistent availability of pharmaceuticals is a cornerstone for patient wellbeing, effective treatment, and equal access to needed medical care. Pharmaceutical supply disruptions ...
Visibility in global supply chains is paramount. But the sheer volume and increasingly complex nature of data involved in international commerce can open the door to fraud, theft and counterfeit goods ...
If the last few years have taught us anything, a safe and secure pharmaceutical cold supply chain is of paramount importance – disruptions can directly put lives at risk. The pandemic highlighted the ...
Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and sourcing strategies (6,7).
The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...
Several breakdown areas in the pharmaceutical supply chain were brought to light by COVID-19, but looking ahead, three areas should be at the core of improvements, experts say: health equity, trust ...
Stocktwits on MSN
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results